Biodexa Pharmaceuticals Plc (BDRX)
Develops experimental medicines for diabetes, cancer, and rare brain diseases using targeted drug delivery technology.
$1.49-0.05%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-95.5%
The outlook
BDRX is trading near its 52-week low, well below both its 50- and 200-day averages, reflecting a weak near-term trend. Analyst coverage is sparse, but the average price target sits significantly above the current price. The overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +572% vs current price
Market cap
$1.3M
52-wk high
$59.40
52-wk low
$1.39
50-day avg
$2.82
200-day avg
$11.63
Trailing P/E
—